
Musgrave PhD scholar in @Surgery_TCD funded by @BreakthroCancer |🔬 microRNA as a therapeutic target in pancreatic cancer | BSc. Pharmacology graduate UCD
Joined September 2022
- Tweets351
- Following385
- Followers260
- Likes1.7K
David Hackett retweeted
I am delighted to share that our review on pancreatic cystic lesions and cancer risk stratification is now published!🎉 Grateful to my supervisors @JoanneLysaght and @sgmaher for their support and excited to celebrate my first first-author PhD publication! doi.org/10.1016/j.tranon.202…
Last week in Boston 🇺🇸, I was delighted to present my work on how microRNA-31-driven alterations in ATOX1 promote chemosensitivity in #PDAC at the @AACR/@theNCI/@EORTC International Conference on Molecular Targets and Cancer Therapeutics.
#PancreaticCancer #Targets25
Extremely grateful to have received a travel grant from @News_IACR to attend this meeting. Huge thanks to @BreakthroCancer & @Musgraveplc for funding this research, and to my supervisors @sgmaher & @prinamea for their continued guidance and support.
David Hackett retweeted
Prof @aislingbarryro Chair of Radiation Oncology at UCC joined @RochfordNiall today as he began his 250km #Cork2Cong walk in memory of his wife Stella 💜.
Niall started his 12-day journey from @UCC where Stella once studied, to raise awareness and funds for pancreatic cancer.
Delighted to present my work at @AACR-@theNCI-@EORTC Intl Conference on Molecular Targets and Cancer Therapeutics in Boston. If you’re at the conference, please stop by my poster tomorrow (C100) to chat about miR-31/ATOX1 targeting in #PDAC #Targets25
aacrjournals.org/mct/article…
David Hackett retweeted
This #WorldPancreaticCancerMonth our Co-founder Niall Rochford will embark on a 12 day, 250km walk from Cork to Cong, Co. Mayo, to raise vital funds and awareness for pancreatic cancer. For more information please visit pancreaticcancerireland.ie/c…
#Cork2Cong #EveryStepCounts
Had a great time volunteering at the @BreakthroCancer Revolution Exhibition in Stephen’s Green Shopping Centre today! Loved @DeasyPamela’s inspiring story—every journey is unique, and this exhibition captures it. Definitely worth a visit!
Free tickets at cancerrevolution.ie
David Hackett retweeted
I had a great time attending and presenting at #ACTC25 in Thessaloniki! All possible due @C_CahillTCD, @oner_ez and @kathygately1 for their constant support and guidance along with TORG lab and @CluB_Cancer1 ! Thanks to @hea_irl for funding.
David Hackett retweeted
Congrats to our @CluB_Cancer1 scientists @VolgaMSaini @C_CahillTCD & @oner_ez showcasing their longitudinal data on #CTCs in early stage #lungcancer at #ACTC25 Thanks to @hea_irl for supporting this important research #NSRPproject @CancerInstIRE @TCDTMI @stjamesdublin #lcsm
David Hackett retweeted
#Notallheroeswearcapes 🦸🏼♂️ some wear white coats 🧑🏼🔬thanks to all Researchers undertaking #research into #pancreaticcancer but a special shout out to @_davidhackett. to all the team @BreakthroCancer for funding research into poorer prognosis cancers, & especially to all donors 💜
💙 At the heart of research, it’s people who make the biggest impact.
PhD researcher @_davidhackett and @DeasyPamela survivor of #PancreaticCancer show how Public and Patient Involvement #PPI builds trust, focus and hope for the future.
Read more 👉 bit.ly/BCRPPI
David Hackett retweeted
Ireland becoming 'world leader' in cancer research rte.ie/news/ireland/2025/081… via @rte
We are proud to support so much extraordinary Irish research and show the exceptional nurses and doctors caring for people with cancer . #cancerrevolution #freeexhibition
David Hackett retweeted
Thanks Vanessa for sharing my story
Hope this will help someone else 💜
#pancreaticcancer #pancreaticcancerawareness #cancerawareness
open.spotify.com/episode/78k…
David Hackett retweeted
PhD student, @Lorrainesmith_1 is exploring a new way to treat Barrett’s oesophagus using electroporation - a gentler method.
Funded by @BreakthroCancer through the @AllCaN_BCR programme, her work could pave the way for a new clinical trial for people with #BarrettsOesophagus
David Hackett retweeted
Huge congrats to @maitiuomurchu on passing his PhD viva today. Very proud. Thanks to his examiners Prof @K_Butterworth and Dr @MartinBarr10 and Prof @JoanneLysaght for chairing. Thanks to @BreakthroCancer for funding this work.
David Hackett retweeted
Congratulations to the formidable Dr Marion on a successful PhD viva! Delighted to see your hard work recognised. Such an impressive body of work revealing the pro-tumourigenic effects of fractalkine in OAC @caroline_mrn @JoanneLysaght @TCDTMI @CancerInstIRE @TrinityMed1
David Hackett retweeted
Early diagnosis of #OvarianCancer could raise survival to 90% - but it’s hard to detect.
At @TCDTMI, Dr. Sharon O’Toole & Marika Kanjuga are developing a blood test to catch it earlier.
Funded by Breakthrough Cancer Research & the Attracta O’Regan Fund 💙
#WOCD2025 @OvCancerDay
Exciting to see amifostine repurposed as a radioprotective agent for pancreatic cancer! Traditionally administered intravenously, a targeted nasal delivery method delivers it directly to the duodenum, where it shields healthy cells from radiation. Now entering clinical trials.
A novel modality for #PancreaticCancer therapy on the cover of @RiceUniversity magazine. The subject of radioprotection was near & dear to Cullen Taniguchi’s heart. I am glad to see progress on this @RiceUniversity - @MDAndersonNews collaboration!
magazine.rice.edu/spring-202…
David Hackett retweeted
Congratulations to @nicraftery who presented at the European Surgical Association yesterday in Geneva on grading of dysplasia in Barrett’s and long-term progression. Thanks to all involved in this significant body of work. @OesophagealCF @ICATProgramme @CancerInstIRE @TrinityMed1
David Hackett retweeted
🔬 Go behind the scenes of cancer research!
Join us on May 8, 2025, at @TCDTMI, Dublin, for a free lab tour. Meet the scientists, explore breakthroughs & see how research saves lives.
🔗 Register now: bit.ly/LabTourMay
#MakingMoreSurvivors #CancerResearch #LabTour






































